Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

about

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

Item

http://www.wikidata.org/entity/Q49844990

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

@en

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

@nl

type

Item

label

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

@en

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

@nl

prefLabel

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

@en

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

@nl

P1476

Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma.

@en

P2093

Bong Kyung Shin

http://www.w3.org/2001/XMLSchema#string

Gyu Young Hur

http://www.w3.org/2001/XMLSchema#string

Jae Jeong Shim

http://www.w3.org/2001/XMLSchema#string

Jae Kyeom Sim

http://www.w3.org/2001/XMLSchema#string

Je Hyeong Kim

http://www.w3.org/2001/XMLSchema#string

Jee Youn Oh

http://www.w3.org/2001/XMLSchema#string

Jong Hyun Choi

http://www.w3.org/2001/XMLSchema#string

Ju Han Lee

http://www.w3.org/2001/XMLSchema#string

Kyung Ho Kang

http://www.w3.org/2001/XMLSchema#string

Kyung Hoon Min

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Pembrolizumab for the treatment of non-small-cell lung cancer

Evaluation of PD-L1 Expression in Tumor Tissue of Patients with Lung Carcinoma and Correlation with Clinical and Demographic Data.

Carcinosarcomas of the lung: a clinicopathologic study of 66 patients.

Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung.

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).

Palliative chemotherapy for pulmonary pleomorphic carcinoma.

Sarcomatoid carcinoma of the lung: a predictor of poor prognosis.

Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report

Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma.

P304

737-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.2017.245

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29458244

http://www.w3.org/2001/XMLSchema#string

P932

6030417

http://www.w3.org/2001/XMLSchema#string